Production Techniques Patents Sample Clauses

Production Techniques Patents. Dow hereby grants to Pfenex a worldwide fully paid up, non-exclusive royalty-free license in the Field, including the right to grant and authorize sublicenses in accordance with Section 2.02, under the Production Techniques Patents to: (a) make, have made, use, sell, offer for sale and import Production Techniques Products; (b) practice any method, process or procedure in connection with its exercise of the activities described in clause (a) above; and (c) otherwise exploit the Production Techniques Patents.
AutoNDA by SimpleDocs
Production Techniques Patents. “Production Techniques Patents” shall mean the Patents owned or Controlled by Dow or its Affiliates as of the Effective Date, or at anytime during the Term, that are necessary or useful for the manufacture, use, or sale of Production Techniques Products, including without limitation, the patents related to production techniques for various proteins as listed in Appendix C.
Production Techniques Patents. 62339A PCT PCT OVER-EXPRESSION OF EXTREMOZYME GENES IN PSEUDOMONADS AND CLOSELY RELATED BACTERIA 2/13/2002 WO2003068926 WO2003068948 PCT/US02/004294 USA 10/504,505 Australia 2003215197 Brazil PI0307630 Canada 0000000 Xxxxx 03808240.3 EPO 03711011.1 [Validation in progress] Xxxxx 0000/0000 Xxxxx 2003-568041 Mexico PA/A/04/007886 61727A USA LOW-COST PRODUCTION OF PEPTIDES 5/22/2002 US20050227321 PCT/US03/12407 PCT Australia 2003228637 Canada 2482995 China 03814541.3 EPO 03726398.5 [Validated in GB, FR, DE, NL, XX] Xxxxx 000/0000 Xxxxx 2003-586175 S. Korea 2004-7017047 61957A PCT PROCESS FOR REMOVING WATER FROM AQUEOUS SOLUTIONS OF PROTEINS 2/27/2004 WO2005092915 USA 10/590095 EPO 05713770.5 Validated in GB, DE, FR, 62644A PCT METHOD FOR THE EXTRACTION OF INTRACELLULAR PROTEINS FROM A FERMENTATION BROTH 2/27/2004 WO2005087791 PCT/US05/005309 USA 60/548403 EPO 05723333.0 USA 10/590185 65217 USA CONTINUOUS OSMOTIC SHOCK PROCESS FOR RELEASE OF PROTEINS FROM BACTERIA 1/12/2007 US Application No: 12/013042 [*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. AU 2008205632 CA PCT/US08/000426 CH PCT/US08/000426 EP 08724501.5 IN PCT/US08/000426 JP PCT/US08/000426 SINGAPORE 200904693-9 SOUTH KOREA PCT/US08/000426 [*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. US Patent No: 7,338,794 entitled “Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant and vaccine accelerant” and any foreign counterpart thereof. [*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Production Techniques Patents. 62339A PCT PCT OVER-EXPRESSION OF EXTREMOZYME GENES IN PSEUDOMONADS AND CLOSELY RELATED BACTERIA 2/13/2002 WO2003068926 WO2003068948 PCT/US02/004294 USA 10/504,505 Australia 2003215197 Brazil PI0307630 Canada 0000000 Xxxxx 03808240.3 EPO 03711011.1 [Validation in progress] Xxxxx 0000/0000 Xxxxx 2003-568041 Mexico PA/A/04/007886 61727A USA LOW-COST PRODUCTION OF PEPTIDES 5/22/2002 US20050227321 PCT/US03/12407 PCT Australia 2003228637 Canada 2482995 China 03814541.3 EPO 03726398.5 [Validated in GB, FR, DE, NL, XX] Xxxxx 000/0000 Xxxxx 2003-586175 S. Korea 2004-7017047 61957A PCT PROCESS FOR REMOVING WATER FROM AQUEOUS SOLUTIONS OF PROTEINS 2/27/2004 WO2005092915 USA 10/590095 EPO 05713770.5 Validated in GB, DE, FR, 62644A PCT METHOD FOR THE EXTRACTION OF INTRACELLULAR PROTEINS FROM A FERMENTATION BROTH 2/27/2004 WO2005087791 PCT/US05/005309 USA 60/548403 EPO 05723333.0 USA 10/590185 65217 USA CONTINUOUS OSMOTIC SHOCK PROCESS FOR RELEASE OF PROTEINS FROM BACTERIA 1/12/2007 US Application No: 12/013042 CONFIDENTIAL - Do not share without permission EXECUTION COPY AU 2008205632 CA PCT/US08/000426 CH PCT/US08/000426 EP 08724501.5 IN PCT/US08/000426 JP PCT/US08/000426 SINGAPORE 200904693-9 SOUTH KOREA PCT/US08/000426 CONFIDENTIAL - Do not share without permission EXECUTION COPY Appendix D ARC Patent US Patent No: 7,338,794 entitled “Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant and vaccine accelerant” and any foreign counterpart thereof. CONFIDENTIAL - Do not share without permission EXECUTION COPY Exhibit 6.06.01 Third Party Agreements

Related to Production Techniques Patents

  • Patent Rights The State and the U. S. Department of Transportation shall have the royalty free, nonexclusive and irrevocable right to use and to authorize others to use any patents developed by the Engineer under this contract.

  • Patent/Copyright Materials/Proprietary Infringement Unless otherwise expressly provided in this Contract, Contractor shall be solely responsible for clearing the right to use any patented or copyrighted materials in the performance of this Contract. Contractor warrants that any software as modified through services provided hereunder will not infringe upon or violate any patent, proprietary right or trade secret right of any third party. Contractor agrees that, in accordance with the more specific requirement contained in paragraph 18 below, it shall indemnify, defend and hold County and County Indemnitees harmless from any and all such claims and be responsible for payment of all costs, damages, penalties and expenses related to or arising from such claim(s), including, but not limited to, attorney’s fees, costs and expenses.

  • Intellectual Property Rights Infringement HP will defend and/or settle any claims against Customer that allege that an HP-branded product or service as supplied under this Agreement infringes the intellectual property rights of a third party. HP will rely on Customer’s prompt notification of the claim and cooperation with our defense. HP may modify the product or service so as to be non-infringing and materially equivalent, or we may procure a license. If these options are not available, we will refund to Customer the amount paid for the affected product in the first year or the depreciated value thereafter or, for support services, the balance of any pre-paid amount or, for professional services, the amount paid. HP is not responsible for claims resulting from any unauthorized use of the products or services.

  • Trademarks, Patents Each of the Borrower and the Subsidiaries possesses or has the right to use all of the patents, trademarks, trade names, service marks and copyrights, and applications therefor, and all technology, know-how, processes, methods and designs used in or necessary for the conduct of its business, without known conflict with the rights of others.

  • Technology Discoveries, innovations, Know-How and inventions, whether patentable or not, including computer software, recognized under U.S. law as intellectual creations to which rights of ownership accrue, including, but not limited to, patents, trade secrets, maskworks and copyrights developed under this Agreement.

  • INTELLECTUAL PROPERTY RIGHTS - INVENTION AND PATENT RIGHTS A. General 1. NASA has determined that 51 U.S.C. § 20135(b) does not apply to this Agreement. Therefore, title to inventions made (conceived or first actually reduced to practice) under this Agreement remain with the respective inventing party(ies). No invention or patent rights are exchanged or granted under this Agreement, except as provided herein.

  • Licensed Intellectual Property Section 3.17(h)(vi)...................................29

  • Infringement of Intellectual Property Rights Seller (or its supplier) shall indemnify and hold Purchaser harmless against an award of damages and costs against Purchaser by a final judgment of a court of last resort in the country in which the Equipment is originally installed by Seller resulting from actual or alleged patent infringement relating in any way to use or sale of the Equipment, or any component thereof furnished hereunder, provided that Purchaser (i) gives Seller immediate notice in writing of any suit or claim for infringement against Purchaser, (ii) permits Seller (or its supplier) to control the defense of any suit or claim, and (iii) gives Seller (or its supplier) all available information, assistance, and authority to enable Seller (or its supplier) to assume such defense. Seller (or its supplier) shall diligently defend and prosecute all such patent infringement litigation and shall keep Purchaser fully informed of all developments in the defense or adjustments of any such claim or action. If a final injunction or judgment in any patent infringement action is rendered restraining Purchaser’s use of the Equipment, or of any component thereof, Seller shall, at its option and expense, either (i) procure for Purchaser the right to use the Equipment, or (ii) replace or modify the infringing component so that it no longer infringes, or (iii) repurchase the Equipment upon its return to Seller, less reasonable depreciation of 2% per month from date of installation, for use, damage, or obsolescence. Seller shall have no liability whatsoever to Purchaser if any such patent infringement or claim thereof is based upon or arises from (i) the use of any Equipment in combination with an apparatus or device not manufactured or supplied by Seller and such combination cause the infringement, (ii) the use of any Equipment in a manner for which it was neither designed nor contemplated, or (iii) any modification of any Equipment by Purchaser, or by Seller at Purchaser’s request, or by any third party, which causes the Equipment to become infringing.

  • Patents As to any patentable subject matter contained in the deliverables, the Contractor agrees to disclose such patentable subject matter to the City. Further, if requested by the City, the Contractor agrees to assign and, if necessary, cause each of its employees to assign the entire right, title, and interest to specific inventions under such patentable subject matter to the City and to execute, acknowledge, and deliver and, if necessary, cause each of its employees to execute, acknowledge, and deliver an assignment of letters patent, in a form to be reasonably approved by the City, to the City upon request by the City.

  • Third Party Technology The Company makes use of third party technology to collect information required for traffic measurement, research, and analytics. Use of third party technology entails data collection. We therefore would like to inform clients the Company enables third parties to place or read cookies located on the browsers of users entering the Company’s domain. Said third parties may also use web beacons to collect information through advertising located on the Company’s web site. Please note that you may change your browser settings to refuse or disable Local Shared Objects and similar technologies; however, by doing so you may be disabling some of the functionality of Company’s services.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!